Cargando…
Chitosan Hydrogel Enhances the Therapeutic Efficacy of Bone Marrow–Derived Mesenchymal Stem Cells for Myocardial Infarction by Alleviating Vascular Endothelial Cell Pyroptosis
Myocardial infarction (MI) is one of the higher mortality rates, and current treatment can only delay the progression of the disease. Experiments have shown that cell therapy could improve cardiac function and mesenchymal stem cells (MSCs)-based therapies provide a great promising approach in the tr...
Autores principales: | Liu, Yang, Li, Panyang, Qiao, Chenhui, Wu, Tiejun, Sun, Xiaoke, Wen, Meng, Zhang, Weihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Cardiovascular Pharmacology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668671/ https://www.ncbi.nlm.nih.gov/pubmed/31663873 http://dx.doi.org/10.1097/FJC.0000000000000760 |
Ejemplares similares
-
Chitosan hydrogel improves mesenchymal stem cell transplant survival and cardiac function following myocardial infarction in rats
por: Xu, Bin, et al.
Publicado: (2017) -
Pyroptosis inhibition improves the symptom of acute myocardial infarction
por: Liu, Wenju, et al.
Publicado: (2021) -
Angiopoietin‐like protein 4 treated bone marrow‐derived mesenchymal stem cells alleviate myocardial injury of patients with myocardial infarction
por: Zhang, Fen, et al.
Publicado: (2022) -
Bone marrow mononuclear cells and acute myocardial infarction
por: Arnous, Samer, et al.
Publicado: (2012) -
Mitofilin Mitigates Myocardial Damage in Acute Myocardial Infarction by Regulating Pyroptosis of Cardiomyocytes
por: Ma, Min, et al.
Publicado: (2022)